Results 241 to 250 of about 8,395 (267)

Pharmacokinetics of metamizol metabolites.

Agents and actions. Supplements, 1986
When administered to humans, metamizol rapidly undergoes predominantly nonenzymatic biotransformation, yielding a vast number of active and later inactive metabolites. The biotransformational pathways and the clinical significance of the metabolites are discussed in the light of their individual pharmacokinetics.
openaire   +1 more source

Metamizole and the risk of drug-induced agranulocytosis and neutropenia in statutory health insurance data

Naunyn-Schmiedeberg's Archives of Pharmacology, 2019
Inke R. König, Markus Schwaninger
exaly  

Toxicity of metamizole on differentiating HL60 cells and human neutrophil granulocytes

Toxicology, 2019
Deborah Rudin, Urs Duthaler, Stephan Krähenbühl   +2 more
exaly  

Metamizol-praktische Anwendung

Der Schmerz, 1988
openaire   +1 more source

Metamizole (Dipyrone) as an Alternative Agent in Postoperative Analgesia in Patients with Contraindications for Nonsteroidal Anti‐Inflammatory Drugs

Pain Practice, 2017
Cornelis Kramers
exaly  

Metamizole

2018
openaire   +1 more source

Gender and functional CYP2C and NAT2 polymorphisms determine the metabolic profile of metamizole

Biochemical Pharmacology, 2014
Inmaculada Andreu, Gemma Amo, Miguel A A Miranda   +2 more
exaly  

Metamizol

1990
openaire   +1 more source

Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case–Control Surveillance Study

European Journal of Clinical Pharmacology, 2014
Reinhold Kreutz
exaly  

A Comparative Investigation of the Analgesic Effects of Metamizole and Paracetamol in Rats

Journal of Investigative Surgery, 2015
İlker İnce, Mehmet Aksoy, Ali Ahiskalioglu   +2 more
exaly